Helix BioPharma Corp. Appoints New COO and Communications Director to Accelerate Growth and Deliver on its Mission Against Hard-to-Treat Cancers

About this update from Helix Biopharma Corp.

[{"type":"text","content":"Helix BioPharma Corp. Appoints New COO and Communications Director to Accelerate Growth and Deliver on its Mission Against Hard-to-Treat Cancers\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Toronto, Ontario –\n \n\n TheNewswire\n– April 24, 2025 -\n \n\n Helix\nBioPharma Corp.\n \n\n (TSX:\n \n\n “HBP”\n \n\n , OTC PINK:\n \n\n “HBPCD”\n \n\n , FRANKFURT:\n \n\n “HBP0”\n \n\n ) (\n \n\n “Helix”\n \n\n or the\n \n\n “Company”\n \n\n ), a clinical-stage oncology company shaping a near future\nwhere today’s hard-to-treat cancers are vincible, today announced\nthe appointments of\n \n\n Veronika\nKandziora\n \n\n as Chief Operating Officer\n(\n \n\n “COO”\n \n\n ) and\n \n\n Jessica\nKourniaktis, DPhil\n \n\n , as Director of\nCommunications of the Company.\n \n\n\n\n Ms. Kandziora is a seasoned executive with over 20\nyears of leadership experience across the biopharma, financial, and\nconsulting sectors, bringing a rare trifecta of administrative acumen,\npeople-centered leadership, and organizational insight to her role as\nCOO of Helix BioPharma. Her long-standing relationship with the\nCompany brings invaluable continuity and deep institutional knowledge\nto this role, having supported corporate strategy, transformation, and\nstakeholder engagement for Helix in Europe and North America. She\npreviously served as Corporate Secretary of Helix (2017–2019) and as\na strategic consultant to the Company’s leadership and Board in the\nyears leading up to her appointment. Alongside these roles, she spent\n15 years as an independent Asset Manager, advising clients on\ncorporate development, intellectual property, and strategic\ninvestments—primarily in the biopharma space. Ms. Kandziora began\nher career in the financial industry in 2003, leading complex\ninternational projects across Germany, Austria, Italy, and\nLiechtenstein, and consulting for wealth managers, trustees, and\ninvestment funds with a focus on biotechnology, technology, and raw\nmaterials. A polyglot with a strong foundation in finance and\ncompliance, Ms. Kandziora holds a Diploma in Management and\nHospitality from the WIFI Academy of Applied Sciences in Austria, and\nis a certified Vocational Trainer in Liechtenstein. She has also\n...

More updates from Helix Biopharma Corp.